Early trials suggest vaccines that activate these immune cells work better and faster and may protect people with weakened immune systems
Are T-cell vaccines better for everyone?
In a combined phase one and two trial, Heitmann's team tested CoVAC-1 in patients who are unable to produce antibodies due to an underlying disease. Preliminary data from 14 participants—many of whom received mRNA vaccine doses that didn’t prove effective—indicated that 13 hadWhether that’s enough to protect against COVID-19, or at least severe outcomes of the disease, is as yet unknown.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Dow finishes 360 points lower as stocks give up strong early gainsStocks ended sharply lower Thursday, reversing strong early gains as Treasury yields saw a renewed rise. The Dow Jones Industrial Average fell around 369 points, or 1%, to finish near 34,792:
Weiterlesen »
Jerseyites show up early and in numbers to recreational marijuana's opening day“My 19-year-old self wouldn't forgive my 51-year-old self if I didn't show up here today,' said a man who used to smoke a lot in his youth, but isn't much of a cannabis user anymore. He wanted to celebrate the 'historic' occasion.
Weiterlesen »
Pterosaur melanosomes support signalling functions for early feathers - NatureMelanosomes preserved in the skin and feathers of a tapejarid pterosaur from the Early Cretaceous found in Brazil provide evidence of the early use of feathers for visual communication.
Weiterlesen »
Covid: Isle of Man sewage testing to give early warning of spreadAn Isle of Man Covid report shows the first waste water test results and records five more deaths.
Weiterlesen »
Honda to slash production by 50% at domestic plant in early MayHonda Motor Co is planning to cut production by about 50% on two lines of one of its domestic factories in early May due to chip shortages and COVID-19 lockdowns, the company said on Thursday.
Weiterlesen »